glp-1 agonist medications Study finds receptor agonists target fat over muscle for weight loss Lower doses of the GLP-1

Coskun T, Sloop KW, Loghin C, et al

Originating in the gut, these hormones are secreted in response to nutrient intake

exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes

Minimal clinically important difference on the motor examination part of MDS-UPDRS

Meta-analyses of clinical trials show that GLP-1 RAs, particularly semaglutide, lead to moderate but clinically meaningful reductions in body weight among adolescents with obesity

"We believe the launch of Saxenda represents a significant contribution to the therapeutic options that are advancing obesity care